371 related articles for article (PubMed ID: 24975321)
41. Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.
Capewell P; Veitch NJ; Turner CM; Raper J; Berriman M; Hajduk SL; MacLeod A
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1287. PubMed ID: 21909441
[TBL] [Abstract][Full Text] [Related]
42. A multi-centre evaluation of the card indirect agglutination test for trypanosomiasis (TrypTect CIATT).
Asonganyi T; Doua F; Kibona SN; Nyasulu YM; Masake R; Kuzoe F
Ann Trop Med Parasitol; 1998 Dec; 92(8):837-44. PubMed ID: 10396343
[TBL] [Abstract][Full Text] [Related]
43. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill.
Vanhollebeke B; Pays E
Mol Microbiol; 2010 May; 76(4):806-14. PubMed ID: 20398209
[TBL] [Abstract][Full Text] [Related]
44. Chemotherapy of human African trypanosomiasis.
Burchmore RJ; Ogbunude PO; Enanga B; Barrett MP
Curr Pharm Des; 2002; 8(4):256-67. PubMed ID: 11860365
[TBL] [Abstract][Full Text] [Related]
45. Whole-genome sequencing of Trypanosoma brucei reveals introgression between subspecies that is associated with virulence.
Goodhead I; Capewell P; Bailey JW; Beament T; Chance M; Kay S; Forrester S; MacLeod A; Taylor M; Noyes H; Hall N
mBio; 2013 Aug; 4(4):. PubMed ID: 23963174
[TBL] [Abstract][Full Text] [Related]
46. Evidence for the occurrence of Trypanosoma brucei rhodesiense sleeping sickness outside the traditional focus in south-eastern Uganda.
Enyaru JC; Odiit M; Winyi-Kaboyo R; Sebikali CG; Matovu E; Okitoi D; Olaho-Mukani W
Ann Trop Med Parasitol; 1999 Dec; 93(8):817-22. PubMed ID: 10715675
[TBL] [Abstract][Full Text] [Related]
47. Will the real Trypanosoma brucei rhodesiense please step forward?
Gibson W
Trends Parasitol; 2002 Nov; 18(11):486-90. PubMed ID: 12473364
[TBL] [Abstract][Full Text] [Related]
48. [Human resistance to African trypanosoma infections].
Perez-Morga D
Bull Mem Acad R Med Belg; 2007; 162(7-9):381-6; discussion 386. PubMed ID: 18429487
[TBL] [Abstract][Full Text] [Related]
49. Apparent lack of a domestic animal reservoir in Gambiense sleeping sickness in northwest Uganda.
Balyeidhusa AS; Kironde FA; Enyaru JC
Vet Parasitol; 2012 Jun; 187(1-2):157-67. PubMed ID: 22245071
[TBL] [Abstract][Full Text] [Related]
50. In vitro anti-trypanosomal activity of synthetic nitrofurantoin-triazole hybrids against Trypanosoma species causing human African trypanosomosis.
Seetsi A; N'da DD; Molefe-Nyembe N; Suganuma K; Ramatla T; Thekisoe O
Fundam Clin Pharmacol; 2024 Feb; 38(1):72-83. PubMed ID: 37479675
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of resistance of African trypanosomes to cytotoxic human HDL.
Hager KM; Hajduk SL
Nature; 1997 Feb; 385(6619):823-6. PubMed ID: 9039915
[TBL] [Abstract][Full Text] [Related]
52. Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance.
Symula RE; Beadell JS; Sistrom M; Agbebakun K; Balmer O; Gibson W; Aksoy S; Caccone A
PLoS Negl Trop Dis; 2012; 6(7):e1728. PubMed ID: 22802982
[TBL] [Abstract][Full Text] [Related]
53. The structure of serum resistance-associated protein and its implications for human African trypanosomiasis.
Zoll S; Lane-Serff H; Mehmood S; Schneider J; Robinson CV; Carrington M; Higgins MK
Nat Microbiol; 2018 Mar; 3(3):295-301. PubMed ID: 29358741
[TBL] [Abstract][Full Text] [Related]
54. Comparison between bloodstream and procyclic form trypanosomes for serological diagnosis of African human trypanosomiasis.
Katende JM; Nantulya VM; Musoke AJ
Trans R Soc Trop Med Hyg; 1987; 81(4):607-8. PubMed ID: 3328347
[TBL] [Abstract][Full Text] [Related]
55. The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease.
Madhavan SM; O'Toole JF
Clin Exp Nephrol; 2014 Apr; 18(2):238-42. PubMed ID: 24233469
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
57. The separation of trypanosomes from blood by anion exchange chromatography: From Sheila Lanham's discovery 50 years ago to a gold standard for sleeping sickness diagnosis.
Lejon V; Büscher P; Nzoumbou-Boko R; Bossard G; Jamonneau V; Bucheton B; Truc P; Lemesre JL; Solano P; Vincendeau P
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007051. PubMed ID: 30817751
[TBL] [Abstract][Full Text] [Related]
58. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
59. Human African trypanosomiasis: clinical presentation and immune response.
Sternberg JM
Parasite Immunol; 2004; 26(11-12):469-76. PubMed ID: 15771682
[TBL] [Abstract][Full Text] [Related]
60. Molecular characterization of field isolates of human pathogenic trypanosomes.
Gibson W
Trop Med Int Health; 2001 May; 6(5):401-6. PubMed ID: 11348534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
